Healthcare - Biotechnology - NASDAQ - US
$ 8.01
-8.98 %
$ 445 M
Market Cap
-4.77
P/E
BALANCE SHEET
286 M
ASSETS
363 M
LIABILITIES
-77.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Foghorn Therapeutics Inc.
| Current Assets | 240 M |
| Cash & Short-Term Investments | 234 M |
| Receivables | 0 |
| Other Current Assets | 6.12 M |
| Non-Current Assets | 45.7 M |
| Long-Term Investments | 0 |
| PP&E | 42.9 M |
| Other Non-Current Assets | 2.82 M |
| Current Liabilities | 58.4 M |
| Accounts Payable | 6.26 M |
| Short-Term Debt | 17 M |
| Other Current Liabilities | 35.1 M |
| Non-Current Liabilities | 305 M |
| Long-Term Debt | 36.6 M |
| Other Non-Current Liabilities | 268 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 80.3 | 345.8 | 101.1 | 92.8 | 15.0 | 40.0 |
| Short Term Investments | 153.7 | 293.6 | 53.2 | 93.0 | 0 | 0 |
| Receivables | 0 | 0 | 300.0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 6.1 | 5.6 | 5.3 | 9.8 | 1.9 | 0.4 |
| Total Current Assets | 240.2 | 345.8 | 459.6 | 190.7 | 16.9 | 40.4 |
| PP&E | 42.9 | 49.4 | 56.1 | 62.3 | 3.7 | 2.1 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.7 | 1.7 | 1.7 | 1.7 | 0.6 |
| Other Long Term Assets | 2.8 | 8.0 | 2.4 | 0.8 | 11 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 285.9 | 404.9 | 519.8 | 255.6 | 22.3 | 43.1 |
| LIABILITIES | ||||||
| Accounts Payable | 6.3 | 5.4 | 3.8 | 3.7 | 3.4 | 2.0 |
| Short Term Debt | 17.0 | 11.9 | 14.0 | 8.0 | 5.5 | 0 |
| Other Current Liabilities | 84 K | 5.0 | 2.6 | 5.2 | 3.7 | 1.4 |
| Total Current Liabilities | 58.4 | 336.8 | 48.7 | 18.8 | 12.7 | 3.5 |
| Long Term Debt | 36.6 | 45.5 | 51.3 | 78.0 | 97.7 | 7.0 |
| Deferred Tax Income | 0 | 0 | 0 | 19.7 | 0 | (0.5) |
| Other Liabilities | 0 | 29 K | 0.1 | 0 | 45 K | 71.8 |
| Total Liabilities | 363.1 | 404.8 | 422.9 | 109.4 | 110.4 | 82.3 |
| EQUITY | ||||||
| Common Stock | 4 K | 4 K | 4 K | 4 K | 1 K | 1 K |
| Retained Earnings | (471.6) | (373.1) | (264.3) | (162.9) | (94.1) | (43.0) |
| Other Accumulative Comprehensive Income/Loss | (0.8) | (4.0) | 10 K | 7 K | (86.6) | (0.6) |
| Total Equity | (77.2) | 0.1 | 96.9 | 146.2 | (88.0) | (39.3) |
| Total Liabilities and Equity | 285.9 | 404.9 | 519.8 | 255.6 | 22.3 | 43.1 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 42.0 | 41.6 | 37.2 | 36.8 | 36.8 | 19.6 |